|Articles|September 16, 2013

Fewer Cases of Antibiotic-Resistant MRSA Infection in the U.S. in 2011

An estimated 30,800 fewer invasive methicillin-resistant Staphylococcus aureus (MRSA) infections occurred in the United States in 2011 compared to 2005, according to a study by Raymund Dantes, MD, MPH, of the Centers for Disease Control and Prevention (CDC), and colleagues.
  
The researchers estimated that 80,461 invasive MRSA infections occurred nationally in 2011. Of those, 48,353 were healthcare-associated community-onset infections (HACO); 14,156 were hospital-onset infections; and 16,560 were community-associated infections, according to the results.
 
Since 2005, national estimated incidence rates have decreased 27.7 percent for HACO infections, 54.2 percent for hospital-onset infections and 5 percent for community-onset infections.
 
Despite these decreases, invasive MRSA infections with onset in the community or outpatient setting remain problematic and represent the majority of invasive MRSA infections. Future research is needed to understand the progression of colonization and non-invasive MRSA infection to invasive infection in outpatient settings. Future prevention efforts should target both community and healthcare transmission, especially among patients with recent hospitalization, the study concludes.

Reference: JAMA Intern Med. Published online Sept.16, 2013. doi:10.1001/jamainternmed.2013.10423.
 


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.